Cargando…
Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure
The risk posed by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) dictates that live-virus research is conducted in a biosafety level 3 (BSL3) facility. Working with SARS-CoV-2 at lower biosafety levels can expedite research yet requires the virus to be fully inactivated. In this study...
Autores principales: | Loveday, Emma K., Hain, Kyle S., Kochetkova, Irina, Hedges, Jodi F., Robison, Amanda, Snyder, Deann T., Brumfield, Susan K., Young, Mark J., Jutila, Mark A., Chang, Connie B., Taylor, Matthew P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066162/ https://www.ncbi.nlm.nih.gov/pubmed/33810401 http://dx.doi.org/10.3390/v13040562 |
Ejemplares similares
-
Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following Vaccination
por: Hedges, Jodi F., et al.
Publicado: (2021) -
Getting “Inside” Type I IFNs: Type I IFNs in Intracellular Bacterial Infections
por: Snyder, Deann T., et al.
Publicado: (2017) -
Expression of human TLR4/myeloid differentiation factor 2 directs an early innate immune response associated with modest increases in bacterial burden during Coxiella burnetii infection
por: Robison, Amanda, et al.
Publicado: (2019) -
A TLR4 agonist liposome formulation effectively stimulates innate immunity and enhances protection from bacterial infection
por: Hedges, Jodi F., et al.
Publicado: (2023) -
Antiviral response mechanisms in a Jamaican Fruit Bat intestinal organoid model of SARS-CoV-2 infection
por: Hashimi, Marziah, et al.
Publicado: (2022)